NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders

COMMERCIAL MEDICINES UNITcontractContracts Finder ↗Ref CM/PHS/14/5434SME suitablecomplete

Estimated value

£50.6m

Awarded value

£41.0m

Awarded 02 Jun 2016

Suppliers

Lots

1 awarded

Published

17 Aug 2018

Deadline 23 Mar 2016

Other contracts from COMMERCIAL MEDICINES UNIT· 10

Most recent notices published by the same contracting authority.

Title	Type	Value	Published
Strategic stockpile of medicines 2017	contract	—	18 Jan 2019
Dynamic Purchasing System (DPS) for the supply of antibiotics and IV fluids	contract	—	14 Jan 2019
Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin	contract	£21.1m	17 Aug 2018
NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables	contract	£15.0m	17 Aug 2018
NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products	contract	£3.8m	17 Aug 2018
National Framework Agreement for the Supply of Immunoglobulin	contract	£187.3m	17 Aug 2018
Contract for the supply of antibiotcs and IV fluids for the treatment of influenza related secondary bacterial infections	contract	—	30 Nov 2017
Antivirals for use in an influenza pandemic, or wide scale epidemic	contract	—	13 Oct 2017
NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions	call off	—	24 Apr 2017
NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A.	contract	—	24 Apr 2017

Cross-buyer view of this supplier's public-sector wins.

No related contracts found.